Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 123.54 Million | USD 1,555.07 Million | 32.50% | 2023 |
The global organ-on-chip market size was worth around USD 123.54 Million in 2023 and is predicted to grow to around USD 1,555.07 Million by 2032 with a compound annual growth rate (CAGR) of roughly 32.50% between 2024 and 2032.
The report analyzes the global organ-on-chip market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the organ-on-chip industry.
The report covers a forecast and an analysis of the organ-on-chip market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based revenue (USD Million). The study includes drivers and restraints of the organ-on-chip market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the organ-on-chip market on a global level.
In order to give the users of this report a comprehensive view of the organ-on-chip market, we have included a competitive landscape and an analysis of Porter’s Five Forces Model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
Organ-on-chip is a 3D microfluidic cell structure chip that simulates a particular organ in the body along with its mechanics and physiological reactions using the computer chip manufacturing method, to execute procedures like breathing, peristalsis, and curing infections. The organ-on-chip plays an important role in the fields of drug discovery and research, as it assists in achieving greater precision in toxicity identification and testing to decrease the chances of drug failure in human clinical trials. In addition, traditional animal models were not guaranteed to correctly imitate human pathophysiology. The organ chip consists of a flexible polymer of the size of the computer memory stick, which has hollow microfluid channels for the cells of a particular human organ that is surrounded by the organ-specific physical microenvironment.
The increasing issues related to one’s health and rising demand for organ culture instruments based on lung and kidney are driving the organ-on-chip market worldwide. In addition, increasing projects by prominent chip organ implementation organizations will further contribute to the organ-on-chip market globally. For example, in 2024, the Netherlands Scientific Research Organization (NWO) discussed its plans for the country’s organ-on-chip initiative that focused on advances and growth of the same.
However, the imitation of the extremely complicated architecture of human organs may limit the organ-on-chip market over the forecast time period. The Asia Pacific region's flourishing healthcare sector and China's elevated median age, which is one of Asia Pacific's most important markets, will further fuel the development of the worldwide organ-on-chip market in the years ahead.
The organ-on-chip market is fragmented based on product, application, and end-user.
Based on product, the organ-on-chip market is classified into kidney-on-chip, lung-on-chip, heart-on-chip, liver-on-chip, and others.
Based on application segment of the organ-on-chip market includes toxicology research, drug discovery, and others.
Based on drug discovery segment is anticipated to dominate the organ-on-chip market in the years ahead.
Based on end-user segment is divided into cosmetic industry, healthcare, and others. The healthcare sector will hold a major share of the market for organ-on-chip globally in the future.
Report Attributes | Report Details |
---|---|
Report Name | Organ-On-Chip Market Research Report |
Market Size in 2023 | USD 123.54 Million |
Market Forecast in 2032 | USD 1,555.07 Million |
Growth Rate | CAGR of 32.50% |
Number of Pages | 255 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Emulate, AxoSim Technologies, CN Bio Innovations, Hurel Corporation, Ascendance Biotechnology, InSphero, Mimetas, Nortis, Organovo Holdings, and Tara Biosystems, And Others |
Segments Covered | By Product, By End-User, By Application, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America will hold a major share of the organ-on-chip market globally, owing to rapid technological advances in the region. The Asia Pacific organ-on-chip market will witness a substantial growth rate in the organ-on-chip market over the forecast time period, due to the region's elevated population base and the flourishing healthcare industry.
Some key players of the organ-on-chip market are
Global Organ-on-chip Market: Product Analysis
Global Organ-on-chip Market: Application Analysis
Global Organ-on-chip Market: End-User Analysis
Global Organ-on-chip Market: Regional Analysis
FrequentlyAsked Questions
Organ-on-chip is a 3D microfluidic cell structure chip that simulates a particular organ in the body along with its mechanics and physiological reactions using the computer chip manufacturing method, to execute procedures like breathing, peristalsis, and curing infections.
The increasing issues related to one’s health and rising demand for organ culture instruments based on lung and kidney are driving the organ-on-chip market worldwide.
According to the report, the global organ-on-chip market size was worth around USD 123.54 Million in 2023 and is predicted to grow to around USD 1,555.07 Million by 2032.
The global organ-on-chip market is expected to grow at a CAGR of 32.50% during the forecast period.
North America will hold a major share of the organ-on-chip market globally, owing to rapid technological advances in the region.
Some key players of the organ-on-chip market are Emulate, AxoSim Technologies, CN Bio Innovations, Hurel Corporation, Ascendance Biotechnology, InSphero, Mimetas, Nortis, Organovo Holdings, and Tara Biosystems.
The global organ-on-chip market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed